Trials / Recruiting
RecruitingNCT06128681
Diagnosis and Comprehensive Treatment of Mediastinal Interventional Technique
Application Value of Respiratory Mediastinal Intervention Technique in Diagnosis and Comprehensive Treatment of Diseases
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 30 (estimated)
- Sponsor
- Dan Liu · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this observational study is to learn whether patients undergoing mediastinal disease diagnosis and combined treatment with intrapacial ultrasound-guided mediastinal opening techniques have greater clinical benefit. The main questions it aims to answer are: * Whether the mediastinal ultrasound-guided mediastinal opening technique is more beneficial for the diagnosis of benign or malignant mediastinal diseases. * Does the mediastinal ultrasound-guided mediastinal opening technique benefit the patient by ablating mediastinal masses using freezing, laser, or other means. Mediastinal diseases were diagnosed by lymph node biopsy combined with NGS, ROSE and other techniques using transairway ultrasound-guided mediastinal opening technique. Ablation of mediastinal malignancies is performed using techniques such as freezing or laser. Transbronchial lung biopsy(TBLB) may also be performed when necessary. Researchers will compare the experimental group with mediastinal opening and the control group without mediastinal opening to see if Mediastinal open technique benefits patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Intraairway ultrasound-guided mediastinal opening technique | Mediastinal intervention for patients with mediastinal imaging abnormalities is performed under general anesthesia to obtain biopsy specimens for detection or elimination of mediastinal masses |
| PROCEDURE | Transbronchial Lung Biopsy (TBLB) | A standardized supplementary procedure performed in all patients with active pulmonary sarcoidosis and fibrosing mediastinitis, regardless of their primary study group assignment, to obtain lung tissue for histopathological diagnosis and disease activity assessment. |
Timeline
- Start date
- 2021-12-01
- Primary completion
- 2026-12-31
- Completion
- 2026-12-31
- First posted
- 2023-11-13
- Last updated
- 2026-02-10
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06128681. Inclusion in this directory is not an endorsement.